threonine and Multiple Myeloma

threonine has been researched along with Multiple Myeloma in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19908 (40.00)18.7374
1990's1 (5.00)18.2507
2000's1 (5.00)29.6817
2010's9 (45.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Fu, ZZ; Huang, QL; Jiang, RY; Wu, DP; Wu, XJ; Yan, S; Yang, BY; Yang, LL; Zhao, RR1
Cornish Carmony, K; Kim, KB; Lee, DM; Lee, W; Park, JE; Sharma, LK1
Kłoczko, J; Ołdziej, AE; Romaniuk, W; Zińczuk, J1
Bocchia, M; Brambilla, CZ; Candi, V; Gozzetti, A; Papini, G; Sirianni, S1
Berenson, JR; Bonavida, B; Chen, H; Li, M; Li, ZW; Sanchez, E; Shen, J; Steinberg, JA; Wang, C1
Bagnati, R; Cereda, R; D'Incalci, M; Livi, V; Marangon, E; Sala, F; Zucchetti, M1
Appel, A1
Gallastegui, N; Groll, M1
Berenson, JR; Chen, H; Hunter, K; Jones-Bolin, S; Li, J; Li, M; Ruggeri, B; Sanchez, E; Wang, C1
Böhm, S; Brunelli, D; Cereda, R; D'Incalci, M; De Braud, F; Delmonte, A; Driessen, C; Gallerani, E; Hess, D; Marangon, E; Marsoni, S; Martinelli, G; Noberasco, C; Sala, F; Sessa, C; Zucchetti, M1
Allievi, C; Berkers, C; Bernareggi, A; Bussolati, B; Camussi, G; Cassin, M; Coscia, M; Costa, G; de Feudis, P; di Giovine, S; Ferracini, R; Ferrero, D; Giai, V; Hunter, K; Inghirami, G; Jones-Bolin, S; Massaia, M; Neri, A; Nicoli, P; Ovaa, H; Palumbo, A; Peola, S; Pescalli, N; Pezzoni, G; Piva, R; Roato, I; Ruggeri, B; Strepponi, I; Tamagno, I; Williams, M; Zhao, H1
Clement, C; de Hon, FD; Ehlers, M; Herrman, J; Kishimoto, T; Ohsugi, Y; Rose-John, S; Taga, T; ten Boekel, E; Yasukawa, K1
Ackermann, A; Baumal, R; Wilson, B1
Coffino, P; Knowles, B; Nathenson, SG; Scharff, MD1
Clamp, JR; Dawson, G1
Buxbaum, J; Scharff, MD1
Bargellesi, A; Periman, P; Scharff, MD1
Lanzerotti, R; Laskov, R; Scharff, MD1
Baumal, R; Potter, M; Scharff, MD1
Buxbaum, J; Franklin, EC; Scharff, MD; Zolla, S1

Reviews

3 review(s) available for threonine and Multiple Myeloma

ArticleYear
[Proteasome inhibitors in cancer therapy].
    Postepy higieny i medycyny doswiadczalnej (Online), 2015, Dec-31, Volume: 69

    Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Dipeptides; Humans; Lactones; Multiple Myeloma; Neoplasms; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Pyrroles; Thiazoles; Threonine

2015
Second Generation Proteasome Inhibitors in Multiple Myeloma.
    Anti-cancer agents in medicinal chemistry, 2017, Volume: 17, Issue:7

    Topics: Animals; Boronic Acids; Bortezomib; Central Nervous System Neoplasms; Drug Discovery; Humans; Lactones; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Proteasome Inhibitors; Pyrroles; Threonine

2017
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2

    Topics: Adult; Aged; Boronic Acids; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasms; Proteasome Inhibitors; Threonine

2013

Trials

1 trial(s) available for threonine and Multiple Myeloma

ArticleYear
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2

    Topics: Adult; Aged; Boronic Acids; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasms; Proteasome Inhibitors; Threonine

2013

Other Studies

17 other study(ies) available for threonine and Multiple Myeloma

ArticleYear
[Preliminary exploration of the metabolic profile and metabolic pathways in newly diagnosed multiple myeloma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2022, Dec-23, Volume: 44, Issue:12

    Topics: Adult; Aged; Biomarkers; Cysteine; Female; Humans; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Methionine; Middle Aged; Multiple Myeloma; Phenylalanine; Reproducibility of Results; Serine; Threonine

2022
Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.
    Chembiochem : a European journal of chemical biology, 2015, Jan-19, Volume: 16, Issue:2

    Topics: Catalytic Domain; Cell Line, Tumor; Cross-Linking Reagents; Humans; Inhibitory Concentration 50; Molecular Probe Techniques; Molecular Probes; Multiple Myeloma; Polyethylene Glycols; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Threonine

2015
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan.
    British journal of haematology, 2010, Volume: 148, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Death; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Male; Melphalan; Mice; Mice, SCID; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Threonine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study.
    Journal of mass spectrometry : JMS, 2010, Volume: 45, Issue:11

    Topics: Acetonitriles; Biphenyl Compounds; Boronic Acids; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Drug Stability; Humans; Irbesartan; Multiple Myeloma; Neoplasms; Proteasome Inhibitors; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles; Threonine

2010
Drugs: More shots on target.
    Nature, 2011, Dec-14, Volume: 480, Issue:7377

    Topics: Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Clinical Trials as Topic; Drug Resistance, Neoplasm; Glycine; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Oligopeptides; Protease Inhibitors; Pyrazines; Survival Rate; Thalidomide; Threonine

2011
Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studies.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 832

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Lactones; Multiple Myeloma; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyrroles; Saccharomyces cerevisiae; Threonine

2012
CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma.
    Leukemia research, 2012, Volume: 36, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Cell Line, Tumor; Dexamethasone; Humans; Lenalidomide; Mice; Mice, SCID; Multiple Myeloma; Thalidomide; Threonine; Xenograft Model Antitumor Assays

2012
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
    Blood, 2008, Mar-01, Volume: 111, Issue:5

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Line; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Endothelial Cells; Enzyme Inhibitors; Humans; Macrophage Colony-Stimulating Factor; Mice; Mice, Nude; Multiple Myeloma; Neoplasms; NF-kappa B; Osteogenesis; Proteasome Inhibitors; Pyrazines; RANK Ligand; Threonine; Treatment Outcome; Ubiquitin; Xenograft Model Antitumor Assays

2008
Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130.
    Cytokine, 1995, Volume: 7, Issue:5

    Topics: Alanine; Antibodies, Monoclonal; Antigens, CD; Gene Library; Genetic Testing; Glutamine; Histidine; Humans; Interleukin-6; Multiple Myeloma; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Receptors, Interleukin; Receptors, Interleukin-6; Signal Transduction; Threonine; Tumor Cells, Cultured

1995
Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis.
    Journal of immunology (Baltimore, Md. : 1950), 1975, Volume: 114, Issue:6

    Topics: Amyloid; Amyloidosis; Animals; Carbon Radioisotopes; Caseins; Endotoxins; Fluorescent Antibody Technique; Immune Sera; Immunoglobulins; Kidney; Leucine; Lipopolysaccharides; Liver; Lung; Lymphocytes; Mice; Mice, Inbred Strains; Multiple Myeloma; Myocardium; Plasma Cells; Salmonella typhi; Spleen; Threonine; Tritium; Valine

1975
Suppression of immunoglobulin synthesis by cellular hybridization.
    Nature: New biology, 1971, May-19, Volume: 231, Issue:20

    Topics: Animals; Carbon Isotopes; Cell Fusion; Cell Line; Cytogenetics; Fibroblasts; gamma-Globulins; Hybridization, Genetic; Immunoglobulins; In Vitro Techniques; Leucine; Mice; Multiple Myeloma; Peptide Biosynthesis; Threonine; Tritium; Valine

1971
The presence of two types of carbohydrate-amino acid linkage in the same glycoprotein.
    Biochemical and biophysical research communications, 1967, Feb-08, Volume: 26, Issue:3

    Topics: Aspartic Acid; Chromatography, Paper; Galactose; gamma-Globulins; Glycoproteins; Hexoses; Mannose; Multiple Myeloma; Neuraminic Acids; Peptides; Serine; Threonine

1967
The synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. VI. Assembly of IgM proteins.
    The Journal of experimental medicine, 1973, Jul-01, Volume: 138, Issue:1

    Topics: Animals; Carbon Isotopes; Culture Media; Electrophoresis, Polyacrylamide Gel; Immune Sera; Immunoglobulin Fragments; Immunoglobulin M; Leucine; Methods; Mice; Mice, Inbred BALB C; Molecular Weight; Multiple Myeloma; Neoplasm Transplantation; Threonine; Transplantation, Homologous; Valine

1973
Synthesis, assembly, and secretion of globulin by mouse myeloma cells. IV. Assembly of IgA.
    Journal of immunology (Baltimore, Md. : 1950), 1972, Volume: 108, Issue:1

    Topics: Animals; Carbon Isotopes; Cell Line; Immunoglobulin A; Immunoglobulins; Leucine; Mice; Multiple Myeloma; Myeloma Proteins; Neoplasms, Experimental; Rabbits; Sheep; Threonine; Valine

1972
Synthesis, assembly and secretion of gamma globulin by mouse myeloma cells. II. Assembly of IgG2b immunoglobulin by MPC 11 tumor and culture cells.
    Journal of molecular biology, 1971, Mar-14, Volume: 56, Issue:2

    Topics: Animals; Carbon Isotopes; Chromatography, DEAE-Cellulose; Culture Techniques; Cycloheximide; Cytoplasm; Electrophoresis; Immunoglobulin G; Immunoglobulins; Leucine; Mice; Molecular Weight; Multiple Myeloma; Neoplasms, Experimental; Threonine; Valine

1971
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG.
    The Journal of experimental medicine, 1971, Nov-01, Volume: 134, Issue:5

    Topics: Animals; Antibody Formation; Carbon Isotopes; Cell Line; Immunoglobulin G; Immunoglobulins; Kinetics; Leucine; Lymph Nodes; Mice; Multiple Myeloma; Peptides; Ribosomes; Threonine; Valine

1971
Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing gamma-chains and light chains.
    The Journal of experimental medicine, 1970, Jul-01, Volume: 132, Issue:1

    Topics: Bence Jones Protein; Bone Marrow Examination; Carbon Isotopes; Chromatography, Gel; Culture Techniques; Cytoplasm; Electrophoresis; Glutamates; Humans; Immunoelectrophoresis; Immunoglobulin G; Immunoglobulins; Leucine; Leukemia, Plasma Cell; Multiple Myeloma; Neoplasm Proteins; Plasma Cells; Threonine; Tritium; Ultracentrifugation; Valine

1970